GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Parmax Pharma Ltd

Parmax Pharma Q2 FY27 Net Profit at 1729.61 Rs. Thousands

RESULTS ◆ Monitor Closely HIGH RISK
📅 Filed on BSE: 16 Nov 2026, 07:36 PM IST  ·  BSE ID: aa9a0bc7-a37b-4799-b216-af25f7a2586c
View Original BSE Filing (PDF)
💡
In Simple Terms
Parmax Pharma reported a profit for the recent quarter, with increased revenue, but also disclosed a fire incident at its plant.
🤖 AI Summary
  • Parmax Pharma reported Net Profit of 1729.61 Rs. Thousands for Q2 FY27.
  • Revenue from operations was 117042.53 Rs. Thousands for the quarter ended September 30, 2026.
  • Total Income reached 139523.09 Rs. Thousands for Q2 FY27.
  • A fire incident on 28.09.2026 at the manufacturing facility damaged assets; losses are currently unascertained.
  • Company wrote back debt of Rs.2.32 Crores, contributing to Other Income.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from operations (Q2 FY27)
117042.53 Rs. Thousands
362.47%
Net Profit / (Loss) for the period (Q2 FY27)
1729.61 Rs. Thousands
Not comparable — limited prior period data.
Revenue from operations (Half Year Ended 30.09.2026)
199252.05 Rs. Thousands
345.42%
Net Profit / (Loss) for the period (Half Year Ended 30.09.2026)
23724.53 Rs. Thousands
Not comparable — limited prior period data.
Basic EPS (Q2 FY27)
0.25 In Rs
Not comparable — limited prior period data.
Equity Share Capital (As at 30.09.2026)
81250.22 Rs. Thousands
🏢 How This Affects the Company
📈
Business Impact
The increase in revenue from operations to 117042.53 Rs. Thousands in Q2 FY27 indicates an expansion in the company's core business activity. The fire incident on September 28, 2026, at the manufacturing facility could affect future production capacity once losses are assessed.
💰
Financial Impact
The company moved from a Net Loss of -20783.66 Rs. Thousands in Q2 FY26 to a Net Profit of 1729.61 Rs. Thousands in Q2 FY27. The write-back of debt amounting to Rs.2.32 Crores directly boosted Other Income.
⚙️
Operational Impact
The fire incident on 28.09.2026 at the manufacturing facility, damaging Plant Machinery, Finished, and Semi-finished Material, impacts operational continuity. Depreciation was not charged on the clean room plant and effluent treatment plant during the half year ended 30th September, 2026.
⚠️
Risk Impact
The unascertained losses from the fire incident on 28.09.2026 at the manufacturing facility introduce an operational and financial risk, as the full extent of damage and its impact on future profitability are not yet quantified in the financial statements.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the reported financial performance, including the Net Profit of 1729.61 Rs. Thousands and the operational disruption from the fire incident. The allotment of 31,37,586 equity shares impacts equity base.
🔍
Management Signal
Management is focusing on improving profitability, as evidenced by the reported net profit and debt write-back. The disclosure of the fire incident indicates transparency in reporting operational challenges.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Assessment of fire incident losses — monitor for further disclosures.
Q3 FY27 financial results — verify sustained profitability and revenue growth.
Audited annual results FY27 — check for final accounting of fire losses and depreciation.
HIGH RISK Unaudited results, significant unascertained losses from a fire incident, and non-charging of depreciation introduce high uncertainty.
💡 Investor Takeaway
Parmax Pharma reported a Net Profit of 1729.61 Rs. Thousands for Q2 FY27. Revenue from operations reached 117042.53 Rs. Thousands, significantly higher than Q2 FY26. A fire incident at the manufacturing facility on 28.09.2026 and its financial impact remain unascertained as of this filing.
⚖️ Strengths & Concerns

✅ Positives

  • Net Profit of 1729.61 Rs. Thousands in Q2 FY27, a turnaround from a -20783.66 Rs. Thousands loss in Q2 FY26.
  • Revenue from operations increased to 117042.53 Rs. Thousands in Q2 FY27, up from 25308.70 Rs. Thousands in Q2 FY26.

⚠️ Concerns

  • A fire incident on 28.09.2026 at the manufacturing facility damaged assets, with the amount of loss yet to be ascertained.
  • Depreciation was not charged on the clean room plant and effluent treatment plant during the half year ended 30th September, 2026, impacting reported expenses.
📅 Company Track Record
Parmax Pharma previously reported a net loss of -5843.31 Rs. Thousands for Q4 FY26 and a wider net loss of -41590.82 Rs. Thousands for the full FY26. The Q2 FY27 results mark a shift to profitability, following board meeting rescheduling for results approval.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Parmax Pharma's Net Profit for Q2 FY27?
Parmax Pharma reported a Net Profit of 1729.61 Rs. Thousands for the quarter ended September 30, 2026 (Q2 FY27).
What was Parmax Pharma's revenue from operations in Q2 FY27?
Revenue from operations for Parmax Pharma in Q2 FY27 was 117042.53 Rs. Thousands, compared to 25308.70 Rs. Thousands in Q2 FY26.
Did a fire incident occur at Parmax Pharma's facility?
Yes, a fire incident took place at Parmax Pharma's manufacturing facility on September 28, 2026, damaging Plant Machinery, Finished, and Semi-finished Material. The management is in the process of ascertaining the amount of loss, and no effect is given in the financial statements for the quarter and half year ended 30.09.2026.
How did Parmax Pharma's half-year financial performance for FY27 compare to FY26?
For the half year ended September 30, 2026, Parmax Pharma reported a Net Profit of 23724.53 Rs. Thousands, a significant improvement from a Net Loss of -28428.63 Rs. Thousands in the corresponding period of FY26.
What was the impact of debt write-back on Parmax Pharma's results?
Parmax Pharma wrote back debt of Rs.2.32 Crores during the half year ended September 30, 2026, which is included as part of Other Income.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses free when you sign up

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel